Amarin Corporation
Amarin Corporation is a biopharmaceutical company founded in 1993 and headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval. competing against GlaxoSmithKline's Lovaza.
primaryTopic
Amarin Corporation
Amarin Corporation is a biopharmaceutical company founded in 1993 and headquartered in Bedminster, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa (AMR-101) received FDA-approval. competing against GlaxoSmithKline's Lovaza.
has abstract
Amarin Corporation is a biopha ...... inst GlaxoSmithKline's Lovaza.
@en
founding year
industry
location
number of employees
thumbnail
type
Link from a Wikipage to an external page
Wikipage page ID
36,552,790
Wikipage revision ID
743,733,050
company name
Amarin Corporation
products
subject
hypernym
comment
Amarin Corporation is a biopha ...... inst GlaxoSmithKline's Lovaza.
@en
label
Amarin Corporation
@en
